ID   SCaBER/R
AC   CVCL_C8D5
DR   Wikidata; Q123033401
RX   PubMed=7656243;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:195316; N-7-(2-(nitrophenyldithio)ethyl)mitomycin C (BMY-25067).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4031; Bladder squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3599 ! SCaBER
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
RX   PubMed=7656243; DOI=10.1016/0304-3835(95)03864-s;
RA   Singh S.V., Xu B.H., Gupta V., Emerson E.O., Zaren H.A., Jani J.P.;
RT   "Characterization of a human bladder cancer cell line selected for
RT   resistance to BMY 25067, a novel analogue of mitomycin C.";
RL   Cancer Lett. 95:49-56(1995).
//